Спонсоры
Novo Nordisk CEO to step down amid market challenges and stock plunge
Сообщение
Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, exceeding 50% since June 2024. Increased competition from compounded versions of Ozempic and Wegovy, along with Eli Lilly's Zepbound gaining market share, contributed to the decision.
Поиск
Категории
- National
- International
- Business
- Technology
- Health
- Образование
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Больше
CIAA probes millions collected by school for unbuilt shops; ex-Minister under scrutiny
BARDIBAS: The Bardibas office of the Commission for the Investigation of Abuse of Authority...
RITES eyes revenue growth through export focus, quality assurance & business diversification: CMD
RITES Ltd is focusing on increased export orders and diversifying its Quality Assurance (QA)...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Russian
